Our client wanted to establish a platform in the UK to build medical sales of its urinary incontinence medicine.
Our syndicated sales team was the only UK resource appointed to promote the product to GPs and hospitals. Our approach was to target very specific decision makers within those environments.
Thanks to Ashfield’s pharmaceutical sales team’s efforts and ingenuity, the product is now being used more widely and sales have increased. One particular Clinical Commissioning Group is switching all patients to the new medication. Our client now has a sound platform upon which to build medical sales.